Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

Faderl, Stefan; Wetzler, Meir; Rizzieri, David; Schiller, Gary; Jagasia, Madan; Stuart, Robert; Ganguly, Siddhartha; Avigan, David; Craig, Michael; Collins, Robert; Maris, Michael; Kovacsovics, Tibor; Goldberg, Stuart; Seiter, Karen; Hari, Parameswaran; Greiner, Jochen; Vey, Norbert; Recher, Christian; Ravandi, Farhad; Wang, Eunice S.; Vasconcelles, Michael; Huebner, Dirk; Kantarjian, Hagop M.

Erstveröffentlichung

2012

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Faderl, Stefan

Wetzler, Meir

Rizzieri, David

Schiller, Gary

Jagasia, Madan

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Journal of Clinical Oncology ; 30 (2012), 20. - S. 2492-2499. - ISSN 0732-183X. - eISSN 1527-7755

Link to publication

https://dx.doi.org/10.1200/JCO.2011.37.9743

Keywords

ACUTE MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROME; STEM-CELL TRANSPLANTATION; PHASE-III TRIAL; ARA-C; CHEMOTHERAPY; MITOXANTRONE; COMBINATION; ETOPOSIDE; MULTICENTER

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record